Synthesis and biological evaluation of the suberoylanilide hydroxamic acid (SAHA) β-glucuronide and β-galactoside for application in selective prodrug chemotherapy
Authors:
- Freddy RivaultFRFreddy Rivault
- Isabelle Tranoy-OpalinskiITIsabelle Tranoy-Opalinski
- Joëlle RocheJRJoëlle Roche
- Jean-Pierre GessonJGJean-Pierre Gesson
- Sébastien PapotSPSébastien Papot
- 1 February 2007
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 17 (4) , 983-986
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Enzyme Specific Activation of Benzoquinone Ansamycin Prodrugs Using HuCC49ΔCH2−β-Galactosidase ConjugatesJournal of Medicinal Chemistry, 2006
- Introduction to the Background, Principles, and State of the Art in Suicide Gene TherapyMolecular Biotechnology, 2005
- Histone deacetylase inhibitorsEuropean Journal of Medicinal Chemistry, 2005
- Antibody-directed enzyme prodrug therapy (ADEPT) for cancerExpert Opinion on Biological Therapy, 2004
- LEAPT: Lectin-directed enzyme-activated prodrug therapyProceedings of the National Academy of Sciences, 2004
- Histone deacetylase inhibitors open new doors in cancer therapyBiochemical Pharmacology, 2004
- Enzyme-Catalyzed Activation of Anticancer ProdrugsPharmacological Reviews, 2004
- Histone Deacetylase InhibitorsJournal of Medicinal Chemistry, 2003
- Antibody-directed enzyme prodrug therapy (ADEPT): a reviewAdvanced Drug Delivery Reviews, 1997
- Gene-directed enzyme prodrug therapy (GDEPT): choice of prodrugsAdvanced Drug Delivery Reviews, 1996